Consistently, in a chronic GVHD model with DBA/2 donors and BALB/c recipients, loss of CD4+ Treg cells was associated with chronic GVHD onset, and infusion of donor-type Treg cells prevented the disease onset or ameliorated the progression of chronic GVHD (96, 97). The gene discussed is CD4; the disease is chronic graft versus host disease.